WEST PALM BEACH, Fla., Jan. 4 -- According to an article in the January 2010 edition of DrugsIn Dermatology (abstract available at http://jddonline.com ), the use of botulinum type A toxins such as Botox and Dysport may offer a cost efficient alternative to the use of selective serotonin reuptake inhibitors. Kenneth Beer MD, who authored
According to Dr. Beer, "So many people take medications for depression that I wondered whether injections with type A botulinum toxins could offer them a better alternative. I collected some very preliminary data comparing the costs of each of the therapies and was surprised at the results."
Dr. Beer cautions that this report needs to be validated with a larger study and he hopes that such a trial will be initiated under the auspices of the National Institute for Mental Health.
SOURCE Kenneth Beer MD
Subscribe to our Free Newsletters!